Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery

Heart Surgery Forum

Volumn 9, Issue 6, 2006, Pages 328-333

  Ibrahim, Khalid ^a   Tjomsland, Ole ^a   Halvorsen, Dag ^a   Wiseth, Rune ^a   Wahba, Alexander ^a   Karevold, Asbjørn ^a   Haaverstad, Rune ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY GRAFT; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLOW MEASUREMENT; FOLLOW UP; GRAFT OCCLUSION; GRAFT PATENCY; HEART MUSCLE BLOOD FLOW; HUMAN; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OFF PUMP CORONARY SURGERY; PEROPERATIVE ECHOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SAPHENOUS VEIN; SURGICAL APPROACH; SURGICAL TECHNIQUE; VEIN GRAFT; COHORT ANALYSIS; DRUG EFFECT; GRAFT SURVIVAL; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VASCULAR PATENCY;

COHORT STUDIES; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33846060154     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20061034     Document Type: Article

References (25)

1. Arsan S, Koray AK, Cisbir SC. 2004. Clopidogrel in coronary artery surgery. Eur J of Cardiothorac Surg 26:869-71.
2. Chu MWA, Wilson SR, Novick RJ, Stitt LW, Quantz MA. 2004. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 78:1536-41.
3. Clarke TA, Waskell LA. 2003. Clopidogrel is metabolized by human cytochrome P450 3A and inhibited by atorvastatin. Drug Metab Dispos 31:53-9.
4. D'Ancona G, Karamanouikan HC, Salerno TA, Schmid S, Bergsland J. 1999. Flow measurement in coronary surgery. Heart Surg Forum 2:121-4.
5. David JL, Limet R. 1999. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost 82:1417-21.
6. Grover FL, Johnson RR, Marshall G, Hammermeister KE. 1994. Impact of mammary grafts on coronary bypass operative mortality and morbidity. Department of Veterans Affairs Cardiac Surgeons. Ann Thorac Surg 57:559-68.
7. Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. 2006. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 29:90-5.
8. Haaverstad R, Vitale N, Tjomsland O, Tromsdal A, Torp H, Samstad SO. 2002. Intraoperative color Doppler ultrasound assessment of LIMA-to-LAD anastomoses in off-pump coronary artery bypasses grafting. Ann Thorac Surg 74:S1390-4.
9. Kapetanakis EI, Medlam DA, Boyce SW, et al. 2005. Administration prior to coronary artery bypasses grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 26:576-83.
10. Kazaz H, Ustonsoy H, Celkan MA, Soydink S, Kayiran C, Bayar E. 2006. Midterm results of off-pump coronary artery bypass surgery in 136 patients: an angiographic control study. J Card Surg 21:6-10.
11. Kim KB, Lim C, Lee C, et al. 2001. Off pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 72:S1033-7.
12. Lau WC, Gurbel PA, Watkins PB, et al. 2004. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 9:166-71.
13. Lev EI, Patel RT, Kelly J, et al. 2006. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47:27-33.
14. Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL. 1999. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 34:1884-90.
15. Muller I, Seyfarth M, Rudiger S, et al. 2001. Effects of a high dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85:92-3.
16. Neubauer H, Gunesdogan B, Hanefeld C, Spiecker M, Mugge A. 2003. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function - a flow cytometry study. Eur Heart J 24:1744-9.
17. Onorati F, De Feo M, Cerasuolo F, et al. 2005. Myocardial protection in diabetics with left main stem disease: which is the best strategy? J Cardiovasc Surg 46:305-12.
18. Parolai A, Alemanni F, Polvani G, et al. 2005. Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Ann Thorac Surg 80:2121-5.
19. Puskas JD, Williams WH, Mahoney EM, et al. 2004. Off-Pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes. A randomized trial. JAMA 291:1841-9.
20. Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. 1999. Clopidogrel loading dose regimens kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 25 (suppl 2):15-9.
21. Thebault JJ, Kieffer G, Cariou R. 1999. Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost 25(suppl 2):3-8.
22. The TIMI study group. 1984. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 33:523-30.
23. Unn KY, Kottke BA, Titus JL, Frye RL, Wallace RB, Brown AL. 1974. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol 34:526-32.
24. Wong CK, French JK, Aylward P, et al. 2005. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol 46:29-38.
25. Yusuf S, Phil D, Zhao F, et al. 2001. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502.